In an article in the February 2005 issue of Cancer Epidemiology, Biomarkers & Prevention (1), the title of the article contained the following error: “sEGFR” was abbreviated as “SEG-FR.” The correct title follows.

Soluble Epidermal Growth Factor Receptor (sEGFR) and Cancer Antigen 125 (CA 125) as Screening and Diagnostic Tests for Epithelial Ovarian Cancer

1
Baron AT, Boardman CH, Lafky JM, et al. Soluble Epidermal Growth Factor Receptor (sEGFR) and Cancer Antigen 125 (CA 125) as screening and diagnostic tests for epithelial ovarian cancer.
Cancer Epidemiol Biomarkers Prev
 
2005
;
14
:
306
–18.
View Original Article
American Association for Cancer Research
2005